Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2699)
All Articles published online
|
Sep 21, 2006 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Höpfner M, Sutter AP, Huether A, Baradari V, Scherübl H. Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer. World J Gastroenterol 2006; 12(35): 5635-5643 [PMID: 17007015 DOI: 10.3748/wjg.v12.i35.5635] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i35/5635.htm |
| Number | Citing Articles |
| 1 |
Gabriel Therizols, Zeina Bash-Imam, Baptiste Panthu, Christelle Machon, Anne Vincent, Julie Ripoll, Sophie Nait-Slimane, Mounira Chalabi-Dchar, Angéline Gaucherot, Maxime Garcia, Florian Laforêts, Virginie Marcel, Jihane Boubaker-Vitre, Marie-Ambre Monet, Céline Bouclier, Christophe Vanbelle, Guillaume Souahlia, Elise Berthel, Marie Alexandra Albaret, Hichem C. Mertani, Michel Prudhomme, Martin Bertrand, Alexandre David, Jean-Christophe Saurin, Philippe Bouvet, Eric Rivals, Théophile Ohlmann, Jérôme Guitton, Nicole Dalla Venezia, Julie Pannequin, Frédéric Catez, Jean-Jacques Diaz. Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance. Nature Communications 2022; 13(1) doi: 10.1038/s41467-021-27847-8
|
| 2 |
Aysun Ozkan, Ayse Erdogan, Odul Ozkan, Esra Manguoglu, Nadir Kiraz. Enhanced anticancer effect of cetuximab combined with stabilized silver ion solution in EGFR-positive lung cancer cells. Turkish Journal of Biochemistry 2019; 44(4): 426 doi: 10.1515/tjb-2018-0033
|
| 3 |
Marc A. Becker, Douglas Yee. EGFR Signaling Networks in Cancer Therapy. 2008; : 147 doi: 10.1007/978-1-59745-356-1_11
|
| 4 |
Sara A. Flanigan, Todd M. Pitts, S. Gail Eckhardt, John J. Tentler, Aik Choon Tan, Andrew Thorburn, Stephen Leong. The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models. Clinical Cancer Research 2010; 16(22): 5436 doi: 10.1158/1078-0432.CCR-10-2054
|
| 5 |
Minoru Haisa. The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer. Journal of International Medical Research 2013; 41(2): 253 doi: 10.1177/0300060513476585
|
| 6 |
Yu Kusada, Yoko Fujita-Yamaguchi. Affinity of anti-insulin-like growth factor Ι receptor antibody binding to the receptor altered by plant lectins. BioScience Trends 2011; 5(3): 93 doi: 10.5582/bst.2011.v5.3.93
|
| 7 |
Ferenc Sipos, Hajnal Székely, Imre Dániel Kis, Zsolt Tulassay, Györgyi Műzes. Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer. World Journal of Gastroenterology 2017; 23(46): 8109-8119 doi: 10.3748/wjg.v23.i46.8109
|
| 8 |
Jordi Rodon, Victoria DeSantos, Robert Jean Ferry, Razelle Kurzrock. Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials. Molecular Cancer Therapeutics 2008; 7(9): 2575 doi: 10.1158/1535-7163.MCT-08-0265
|
| 9 |
Qi Qi, Keqiang Ye. The roles of PIKE in tumorigenesis. Acta Pharmacologica Sinica 2013; 34(8): 991 doi: 10.1038/aps.2013.71
|
| 10 |
Sara A. Flanigan, Todd M. Pitts, Timothy P. Newton, Gillian N. Kulikowski, Aik Choon Tan, Martine C. McManus, Anna Spreafico, Maria I. Kachaeva, Heather M. Selby, John J. Tentler, S. Gail Eckhardt, Stephen Leong. Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models. Clinical Cancer Research 2013; 19(22): 6219 doi: 10.1158/1078-0432.CCR-13-0145
|
| 11 |
Erin A. Donovan, Shivaani Kummar. Role of insulin-like growth factor-1R system in colorectal carcinogenesis. Critical Reviews in Oncology/Hematology 2008; 66(2): 91 doi: 10.1016/j.critrevonc.2007.09.003
|
| 12 |
Mario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, Chiara Pierantoni, Fotios Loupakis, Alberto Zaniboni, Eva Galizia, Lucio Giustini, Rosa Rita Silva, Renato Bisonni, Rossana Berardi, Simona Biagetti, Stefano Menzo, Alfredo Falcone, Italo Bearzi, Stefano Cascinu. Insulin‐like growth factor 1 expression correlates with clinical outcome in K‐RAS wild type colorectal cancer patients treated with cetuximab and irinotecan. International Journal of Cancer 2010; 127(8): 1941 doi: 10.1002/ijc.25193
|
| 13 |
Rong Zhang, Guo-Liang Xu, Yin Li, Long-Jun He, Li-Ming Chen, Guo-Bao Wang, Shi-Yong Lin, Guang-Yu Luo, Xiao-Yan Gao, Hong-Bo Shan. The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma. Journal of International Medical Research 2013; 41(4): 1228 doi: 10.1177/0300060513487631
|
| 14 |
Rabea Oberthür, Henning Seemann, Julia Gehrig, Margret Rave-Fränk, Felix Bremmer, Rovena Halpape, Lena-Christin Conradi, Jens-Gerd Scharf, Peter Burfeind, Silke Kaulfuß. Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death. Cancer Letters 2017; 407: 93 doi: 10.1016/j.canlet.2017.08.009
|
| 15 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives. World Journal of Gastroenterology 2008; 14(46): 7021-7032 doi: 10.3748/wjg.14.7021
|
| 16 |
Deeksha Vishwamitra, Suraj Konnath George, Ping Shi, Ahmed O. Kaseb, Hesham M. Amin. Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget 2017; 8(1): 1814 doi: 10.18632/oncotarget.12123
|
| 17 |
Sarah Kraus, Nadir Arber. Colorectal cancer chemoprevention: Ready for practice?. European Journal of Cancer 2009; 45: 360 doi: 10.1016/S0959-8049(09)70051-6
|
| 18 |
Ayunadirah Ayub, Wai Kien Yip, Heng Fong Seow. Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell line. Biomedicine & Pharmacotherapy 2015; 75: 40 doi: 10.1016/j.biopha.2015.08.031
|
| 19 |
Joseph A. Ludwig, Salah-Eddine Lamhamedi-Cherradi, Ho-Young Lee, Aung Naing, Robert Benjamin. Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug Resistance. Cancers 2011; 3(3): 3029 doi: 10.3390/cancers3033029
|
| 20 |
Hong You, Geoffrey N. Gobert, Malcolm K. Jones, Wenbao Zhang, Donald P. McManus. Signalling pathways and the host‐parasite relationship: Putative targets for control interventions against schistosomiasis. BioEssays 2011; 33(3): 203 doi: 10.1002/bies.201000077
|
| 21 |
XIAO HONG BAO, YOSHIO NAOMOTO, HUI FANG HAO, NOBUYUKI WATANABE, KAZUFUMI SAKURAMA, KAZUHIRO NOMA, TAKAYUKI MOTOKI, YASUKO TOMONO, TAKUYA FUKAZAWA, YASUHIRO SHIRAKAWA, TOMOKI YAMATSUJI, JUNJI MATSUOKA, MUNENORI TAKAOKA. IGF-IR and its inhibitors in gastrointestinal carcinomas (Review). Oncology Letters 2010; 1(1): 195 doi: 10.3892/ol_00000036
|
| 22 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World Journal of Gastroenterology 2008; 14(1): 1-14 doi: 10.3748/wjg.14.1
|
| 23 |
Teresa Troiani, Erika Martinelli, Floriana Morgillo, Anna Capasso, Anna Nappi, Vincenzo Sforza, Fortunato Ciardiello. Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?. Therapeutic Advances in Medical Oncology 2013; 5(1): 51 doi: 10.1177/1758834012462462
|
| 24 |
Scott C. Mayer, Annette L. Banker, Frank Boschelli, Li Di, Mark Johnson, Cynthia Hess Kenny, Girija Krishnamurthy, Kristina Kutterer, Franklin Moy, Susan Petusky, Malini Ravi, Diane Tkach, Hwei-Ru Tsou, Weixin Xu. Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorganic & Medicinal Chemistry Letters 2008; 18(12): 3641 doi: 10.1016/j.bmcl.2008.04.044
|
| 25 |
Marc A. Becker, Douglas Yee. Insulin-like Growth Factors and Cancer. 2012; : 73 doi: 10.1007/978-1-4614-0598-6_4
|
| 26 |
Juan Wang, Fengxiang Huang, Zhun Bai, Bixia Chi, Jiacai Wu, Xu Chen. Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway. International Journal of Molecular Sciences 2015; 16(8): 19851 doi: 10.3390/ijms160819851
|
| 27 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectives. World Journal of Gastroenterology 2008; 14(16): 2461-2473 doi: 10.3748/wjg.14.2461
|
| 28 |
Stella Nikolaou, Shengyang Qiu, Francesca Fiorentino, Shahnawaz Rasheed, Paris Tekkis, Christos Kontovounisios. The prognostic and therapeutic role of hormones in colorectal cancer: a review. Molecular Biology Reports 2019; 46(1): 1477 doi: 10.1007/s11033-018-4528-6
|
| 29 |
H-B. Shan, R. Zhang, Y. Li, G-L. Xu, G-Y. Luo, X-Y. Gao, H-L. Yang. Expression of IGF-1R in Colorectal Polyps and its Role in Colorectal Carcinogenesis. Technology in Cancer Research & Treatment 2011; 10(4): 381 doi: 10.7785/tcrt.2012.500215
|
| 30 |
Christopher Christophi, Nadia Harun, Theodora Fifis. Liver Regeneration and Tumor Stimulation—A Review of Cytokine and Angiogenic Factors. Journal of Gastrointestinal Surgery 2008; 12(5): 966 doi: 10.1007/s11605-007-0459-6
|
| 31 |
Silke Kaulfuβ, Peter Burfeind, Jochen Gaedcke, Jens-Gerd Scharf. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis. Molecular Cancer Therapeutics 2009; 8(4): 821 doi: 10.1158/1535-7163.MCT-09-0058
|